$136.91
9.097.11%
Last update: Nov 10, 4:00 PM
Mesa Laboratories Inc
MLABNASDAQ
Mesa Laboratories rose 56.2% from $81.83 to $127.82, ahead of the S&P 500's +10.0%. Its worst day was Mar 10 (−16.5%), and its low came Nov 21 at $70.60.
Nov 10, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Mesa Laboratories closed at its lowest level of the year, 13.7% below where the year started.
−1.4%, on 740K shares, the year's heaviest volume · S&P 500 +1.0%
Mesa Laboratories shares rose 9.8%, while the S&P 500 rose 0.7%.
Story events cover the past 12 months · Times ET
+9.8% · S&P 500 +0.7%
EPS of $3.07 beat the $1.60 estimate on $65.1M revenue (est. $63.5M).
+8.7% · S&P 500 −0.8%
Mesa Laboratories shares fell 16.5%, while the S&P 500 fell 0.2%.
−16.5%, the year's worst day · S&P 500 −0.2%
EPS of $3.30 beat the $1.47 estimate on $63.7M revenue (est. $65.2M).
−14.5% · S&P 500 0.0%
EPS of $2.68 beat the $2.40 estimate on $60.1M revenue (est. $60.9M).
+9.5% · S&P 500 −0.3%
Mesa Laboratories shares rose 10.9%, while the S&P 500 rose 0.2%.
+10.9% · S&P 500 +0.2%
Mesa Laboratories closed at its highest level of the year, 73.8% above where the year started.
+7.3% · S&P 500 +0.7%
Where it ended: a close of $127.82 on Nov 9, 2026. Up next: Q3 2027 earnings on Feb 2, 2027 (EPS est. $2.71, revenue est. $66.0M).
As of the Nov 9, 2026 close
Replay the year: the line draws itself and stops at each of the 8 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for MLAB and SPY from Benzinga historical bars. Not investment advice.
